Skip to main content

Advertisement

Log in

Clinical trials for the treatment of systemic sclerosis/scleroderma

  • Clinical Trials Review
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dau PC, Kahaleh MB, Sagebiel RW: Plasmapheresis and immunosuppressive drug therapy in scleroderma. Arthritis Rheum 1981, 24:1128–1136.

    Article  PubMed  CAS  Google Scholar 

  2. Akesson A, Wolheim FA, Thysell H,: et al.: Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis. Scand J Rheumatol 1988, 17:313–323.

    PubMed  CAS  Google Scholar 

  3. Silver RM, Warrick JH, Kinsella MB, et al.: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 1993, 20:838–844.

    PubMed  CAS  Google Scholar 

  4. Steen VD, Lanz JK Jr., Conte C, et al.: Therapy for severe interstital lung disease in systemic sclerosis. Arthritis Rheum 1994, 37:1290–1296.

    Article  PubMed  CAS  Google Scholar 

  5. Earle L, Jimenez SA, Steiner RM, et al.: A Pilot Study of Intermittent Intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease. J Rheumatol 1998, 25:1325–1329.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varga, J., Ponor, I. Clinical trials for the treatment of systemic sclerosis/scleroderma. Curr Rheumatol Rep 1, 13–14 (1999). https://doi.org/10.1007/s11926-999-0018-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-999-0018-0

Keywords

Navigation